Clinical Journal of Sport Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 26, 2024
Exercise
is
a
salient
component
in
delaying
disability
progression
multiple
sclerosis
(MS).
This
study
considers
personal
preferences
regarding
exercise
program
prescription
and
the
resources
needed
to
facilitate
exercise.
Journal of Neurology Neurosurgery & Psychiatry,
Journal Year:
2024,
Volume and Issue:
95(11), P. 1077 - 1088
Published: Feb. 28, 2024
Parkinson’s
disease
(PD)
is
an
incurable
and
progressive
neurological
disorder
leading
to
deleterious
motor
non-motor
consequences.
Presently,
no
pharmacological
agents
can
prevent
PD
evolution
or
progression,
while
symptomatic
treatments
have
limited
effects
in
certain
domains
cause
side
effects.
Identification
of
interventions
that
prevent,
slow,
halt
mitigate
the
therefore
pivotal.
Exercise
safe
represents
a
cornerstone
rehabilitation,
but
exercise
may
even
more
fundamental
benefits
could
change
clinical
practice.
In
PD,
existing
knowledge
base
supports
as
(1)
protective
lifestyle
factor
preventing
(ie,
primary
prevention),
(2)
potential
disease-modifying
therapy
secondary
prevention)
(3)
effective
treatment
tertiary
prevention).
Based
on
current
evidence,
paradigm
shift
proposed,
stating
should
be
individually
prescribed
medicine
persons
with
at
early
stage,
alongside
conventional
medical
treatment.
Multiple Sclerosis Journal,
Journal Year:
2024,
Volume and Issue:
30(4-5), P. 605 - 611
Published: Feb. 9, 2024
We
documented
reporting
and
rates
of
drop-out,
adherence,
compliance
from
40
randomized
controlled
trials
(RCTs)
included
in
our
meta-analysis
on
safety
exercise
training
(ET)
MS.
adopted
definitions
metrics
adherence
provided
by
the
MoXFo
group.
Drop-out
was
reported
100%
RCTs
approximated
10%
for
intervention
control
conditions.
Adherence
were
approximately
50%
RCTs,
respectively,
80%
70%,
respectively.
Standardized
are
important
future
understanding
impact
outcomes
translation
research
evidence
into
practice.
Brain-derived
neurotrophic
factor
(BDNF)
is
a
neurotrophin,
acting
as
signal
and
neuromodulator
in
the
central
nervous
system
(CNS).
BDNF
synthesized
from
its
precursor
proBDNF
within
CNS
peripheral
tissues.
Through
activation
of
NTRK2/TRKB
(neurotrophic
receptor
tyrosine
kinase
2),
promotes
neuronal
survival,
synaptic
plasticity,
growth,
whereas
it
inhibits
microglial
release
pro-inflammatory
cytokines.
dysregulated
different
neurodegenerative
diseases
depressions.
However,
there
major
controversy
concerning
levels
stages
multiple
sclerosis
(MS).
Therefore,
this
review
discusses
potential
role
signaling
MS,
how
modulators
affect
pathogenesis
outcomes
disease.
International Journal of MS Care,
Journal Year:
2025,
Volume and Issue:
27(Q1), P. 42 - 49
Published: Feb. 10, 2025
ABSTRACT
BACKGROUND:
Physical
activity
guidelines
for
multiple
sclerosis
(MS)
were
first
published
in
2013.
is
safe
and
beneficial
MS,
yet
it
unclear
if
physical
levels
are
changing
real-world
settings.
METHODS:
The
primary
objective
of
this
study
to
determine
the
people
with
MS
changing.
Between
September
1,
2014,
February
22,
2022,
when
accessed
a
provincial
drugs
program
Saskatchewan,
Canada,
they
invited
complete
Godin
Leisure-Time
Exercise
Questionnaire
by
mail.
Scatter
plots
total
(TPA)
health
contribution
(HC)
scores
generated
from
each
person's
questionnaire.
Multivariable
linear
regression
explored
associations
interactions
between
disease-modifying
treatment
(DMT),
sex,
age,
age
at
onset,
disease
duration
on
level.
RESULTS:
response
rate
was
50.8%
(505
responses
993
requests).
Of
respondents,
69.7%
female;
mean
42.8
(±
11.5)
years;
median
6.0
years
(IQR,
2.0-14.0);
47.4%
had
prior
DMT
exposure.
There
no
significant
change
new
registrants
over
7
(regression
slopes
TPA:
0.71,
P
=
.26;
HC:
0.61,
.21).
Men
reported
higher
than
women
(TPA:
β
11.95;
<
.001;
6.65;
.001).
0.03;
.003;
exposure
not
associated
activity.
CONCLUSIONS:
remained
suboptimal
benefits
7-year
period.
Future
research
should
include
how
use
impact
levels.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 1021 - 1021
Published: March 14, 2025
Background:
There
is
emerging
interest
in
obesity
and
its
prevalence,
outcomes,
management
people
with
multiple
sclerosis
(MS).
Body
mass
index
(BMI)
the
traditional
marker
of
MS,
whereas
body
composition,
inclusive
specific
tissue
compartments
(e.g.,
fat,
bone,
muscle),
often
overlooked
despite
relevance.
Objective:
This
narrative
review
(a)
underscored
use
utility
dual-energy
X-ray
absorptiometry
(DEXA)
as
an
accurate
reliable
measure
composition;
(b)
thematically
analyzed
synthesized
current
evidence
regarding
composition
(using
DEXA);
(c)
determined
gaps
to
be
addressed
future
research.
Methods:
The
structure
reporting
this
followed
guiding
criteria
outlined
Scale
for
Assessment
Narrative
Review
Articles
(SANRA).
relevant
literature
was
identified
via
a
PubMed
search
utilizing
combined
terms
such
‘body
composition’
‘multiple
sclerosis’.
research
then
organized
by
authors
into
major
themes
sub-themes.
articles
described
within
were
based
on
saturation
Results:
Three
identified,
namely
(1)
comparison
between
MS
non-MS
controls
(2
meta-analyses);
(2)
examination
relationships
range
outcomes
(14
cross-sectional
studies);
(3)
interventions
that
report
and/or
target
(11
clinical
trials).
Conclusions:
mapped
existing
posits
novel,
informative,
targeted
concept
population.
underscores
importance
randomized
controlled
trials
focus
significant
modifiable
outcome.
Such
could
improve
understanding
poor
identify
useful
recommendations
diagnosis
management.
BMC Sports Science Medicine and Rehabilitation,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: April 23, 2025
Abstract
Background
We
evaluated
the
effects
of
a
12-week
internet-based
exercise
and
physical
activity
promotion
program
for
persons
with
multiple
sclerosis.
Methods
performed
multicenter,
randomized,
waitlist-controlled
study.
The
intervention
group
(IG)
received
program,
followed
by
12
weeks
usual
care.
control
(CG)
care
only.
main
components
were:
(1)
tailored
home-based
prescription,
(2)
e-learning
resources,
(3)
telephone
video
meetings
an
therapist,
(4)
provision
consumer-based
PA
monitor.
Measurements
were
taken
at
baseline,
postintervention,
after
24
weeks.
primary
outcome
was
device-measured
steps/day.
Other
outcomes
moderate-to-vigorous
activity,
subjectively
measured
leisure-time
transportation
sport/exercise,
activity-related
health
competence,
walking
ability,
quality
life,
fatigue,
depression,
PA-related
self-concordance.
compared
changes
from
baseline
to
postintervention
between
groups
analyzed
in
IG
during
follow-up.
Results
Analysis
56
sclerosis
(IG:
n
=
29,
CG:
27,
age:
45.6
±
10.9)
revealed
no
significant
effect
on
However,
improvements
observed
life
(physical).
During
follow-up,
sport/exercise
decreased
significantly.
Leisure-time
increased
Conclusions
Our
study
provides
first
evidence
that
developed
can
increase
aspects
A
trial
larger
sample
is
recommended
confirm
our
results
examine
mechanisms.
Trial
registration
Registry:
Clinicaltrials.gov;
number:
NCT04367389;
date
registration:
2020-04-21
(retrospectively
registered).
AbstractBackground:
Research
demonstrates
that
exercise
training
is
both
safe
and
beneficial
for
individuals
with
multiple
sclerosis
(MS).
There
a
timely
opportunity
updating
the
guidelines
in
MS,
as
number
of
RCTs
examining
effects
on
range
functional
biomedical
outcomes
among
adults
MS
has
increased
substantially
past
decade.
The
evidence
should
be
gathered
through
rigorous
methodology,
thereby
ensuring
comprehensive
analysis.
This
systematic
review
literature
will
evaluate
type
dose
necessary
to
improve
fitness,
biomarkers
health
disease,
physical
cognitive
functions,
symptoms
quality
life,
and/or
participation
activities
daily
life
presenting
mild,
moderate,
or
severe
disability.
Methods:
This
protocol
follows
PRISMA-P
was
registered
Prospero.
We
undertake
search
conducted
across
8
electronic
bibliographic
databases.
Retrieved
references
screened
by
two
authors
based
pre-established
inclusion
exclusion
criteria.
Relevant
data
extracted
into
piloted
tables
synthesized
qualitatively.
Methodological
included
studies
determined
using
Tool
Assessment
Study
Reporting
Exercise
(TESTEX).
Risk
bias
assessed
revised
Cochrane
risk-of-bias
tool
(RoB
2).
Finally,
certainty
provided
interest
evaluated
Grading
Recommendations
Assessment,
Development
Evaluation
(GRADE)
guidelines.
Discussion:
The
analyzed
this
crucial
our
next
step
MS.
These
updated
provide
people
their
families
caregivers,
well
care
professionals
services
organization
advocates,
clear
information
promote
patients
subsequently
facilitate
implementation
programs
MS-care.
Registration
details:
PROSPERO
registration
CRD42025628825
Frontiers in Physiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 13, 2024
Multiple
sclerosis
(MS)
is
a
chronic
autoimmune
disease
characterized
by
inflammation
and
demyelination
in
the
central
nervous
system
(CNS)
with
subsequent
axonal
neuronal
degeneration.
These
changes
are
associated
broad
range
of
symptoms
including
skeletal
muscle
dysfunction.
Importantly,
musculoskeletal
impairments
manifest
various
ways,
compromise
quality
life
often
precede
later
development
mobility
disability.
As
current
standard
modifying
therapies
for
MS
predominantly
act
on
neuroinflammation,
practitioners
patients
face
an
unmet
medical
need
adjunct
specifically
targeting
function.
This
review
intended
to
detail
nature
dysfunctions
common
people
(pwMS),
describe
underlying
intramuscular
alterations
outline
evidence-based
therapeutic
approaches.
Particularly,
we
discuss
emerging
role
aerobic
resistance
exercise
reducing
perception
fatigue
increasing
strength
pwMS.
By
integrating
most
recent
literature,
conclude
that
both
interventions
should
ideally
be
implemented
as
early
possible
they
can
address
MS-specific
impairments.
Aerobic
particularly
beneficial
pwMS
suffering
from
metabolic
impairments,
while
training
efficiently
counters
weakness
improves
fatigue.
Thus,
these
lifestyle
or
pharmacological
mimetics
have
potential
improving
general
well-being
delaying
functional
declines
relevant
mobility.